RxDoctor Payments Data

Rachel Watts

Family · North Augusta, SCNPI 1992302699

Payments from drug & device makers

$1,916in general payments, 2019–2025

Across 110 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$387
  • AbbVie$345
  • AstraZeneca$203
  • Novo Nordisk$168
  • Pfizer$125
  • GSK$122
  • plus $566 from 15 others

What the payments were for

  • Food & beverage$1,916100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,916 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$103,845
Medicare patients
590
Services billed
1,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$60,751
MounjaroTirzepatide31$57,517
EliquisApixaban35$37,708
JardianceEmpagliflozin22$22,738
EntrestoSacubitril/Valsartan16$22,710
TrintellixVortioxetine Hydrobromide13$6,407
Tresiba Flextouch U-100Insulin Degludec13$5,946
Albuterol Sulfate HfaAlbuterol Sulfate69$2,140
Atorvastatin Calcium185$1,788
Rosuvastatin Calcium108$1,559
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,496
Levothyroxine Sodium163$1,222
Bupropion XlBupropion Hcl32$1,124
Estradiol19$1,124
Gabapentin72$1,081

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$168$60,75144 claims
Lilly USA, LLCMounjaro$387$57,51731 claims
PfizerEliquis$125$37,70835 claims
Boehringer IngelheimJardiance$110$22,73822 claims
NovartisEntresto$17$22,71016 claims
AbbVieSynthroid$345$89718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,248 family providers in South Carolina.

Other family in North Augusta

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →